Basic information |
Metabolite name | myo-Inositol/(Creatine and Phosphocreatine) ratio |
N/A | |
N/A | |
N/A | |
Synonyms | Myo-ionisitol/(Creatine and Phosphocreatine) ratio; |
No. of studies | 28 |
Relationship between myo-Inositol/(Creatine and Phosphocreatine) ratio and depression (count: 28) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M225 | Type1 | depression group vs. control group | Dorsolateral white matter | Human | Up |
Study M228 | Type1 | depression group vs. control group | Frontal lobe | Human | Down |
Study M245 | Type1 | depression group vs. control group | Anterior cingulate cortex/Prefrontal cortex | Human | Down |
Study M255 | Type1 | depression group vs. control group | Anterior cingulate cortex | Human | Up |
Study M259 | Type1 | depression group vs. control group | Hippocampus | Human | Up |
Study M259 | Type1 | depression group vs. control group | Frontal lobe | Human | Up |
Study M259 | Type2 | SSRI-treated depression group post-treatment vs. pre-treatment | Frontal lobe | Human | Down |
Study M265 | Type1 | unmedicated depression group vs. control group | Basal ganglia | Human | Up |
Study M267 | Type2 | SSRI-treated depression group post-treatment vs. pre-treatment | Dorsolateral prefrontal cortex | Human | Up |
Study M271 | Type1 | depression group vs. control group | Thalamus | Human | Down |
Study M271 | Type1 | depression group vs. control group | Hypothalamus | Human | Down |
Study M276 | Type3 | FST + DMI group vs. FST group | Dorsolateral prefrontal cortex | Sprague-Dawley rat | Down |
Study M279 | Type1 | depression group vs. control group | Prefrontal cortex | Human | Down |
Study M279 | Type2 | rTMS-treated responder group post-treatment vs. pre-treatment | Prefrontal cortex | Human | Up |
Study M281 | Type1 | depression group vs. control group | Frontal lobe | Human | Up |
Study M289 | Type1 | recurrent depression group vs. control group | Prefrontal cortex | Human | Up |
Study M289 | Type1 | first-episode depression group vs. control group | Prefrontal cortex | Human | Up |
Study M294 | Type1 | CMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
Study M306 | Type1 | depression group vs. control group | Hippocampus | Human | Up |
Study M309 | Type1 | hypobaric hypoxia group vs. control group | Frontal cortex | Sprague-Dawley rat | Up |
Study M315 | Type1 | AD with depression group vs. AD without depression group | Anterior cingulate gyrus | Human | Up |
Study M318 | Type1 | migraine with depression group vs. migraine without depression group | Dorsolateral prefrontal cortex | Human | Up |
Study M319 | Type1 | depression group vs. control group | Hippocampus | Human | Up |
Study M326 | Type1 | depression group vs. control group | Insula | Human | Down |
Study M326 | Type2 | MBCT-treated depression group post-treatment vs. pre-treatment | Caudate | Human | Down |
Study M334 | Type1 | depression group vs. control group | Dorsal prefrontal cortex | Human | Up |
Study M338 | Type1 | control group vs. sham group | Hippocampus | Wistar rat | Up |
Study M338 | Type2 | EPA + E group vs. EPA group | Hippocampus | Wistar rat | Down |
Study M338 | Type2 | ALA + E group vs. ALA group | Hippocampus | Wistar rat | Down |
Study M338 | Type2 | DHA + E group vs. DHA group | Hippocampus | Wistar rat | Down |
Study M338 | Type2 | NC + E group vs. NC group | Hippocampus | Wistar rat | Down |
Study M343 | Type1 | severe depression group vs. control group | Thalamus | Human | Up |
Study M343 | Type1 | moderate depression group vs. control group | Thalamus | Human | Up |
Study M345 | Type1 | depression group vs. control group | Anterior cingulate cortex | Human | Down |
Study M491 | Type1 | post-CFSS vs. pre-CFSS | Prefrontal cortex | Wistar rat | Up |
Study M521 | Type1 | CUMS group vs. control group | Hippocampus | Wistar rat | Up |
Study M733 | Type3 | fluoxetine group vs. control group, day 1 | Medial prefrontal cortex | Sprague-Dawley rat | Down |
Study M752 | Type1 | PSD group vs. control group | Hippocampus | Wistar rat | Up |
Study M752 | Type1 | PSD group vs. control group | Prefrontal cortex | Wistar rat | Up |
Study M752 | Type2 | PSD + Yi-nao-jie-yu decoction group vs. PSD group | Hippocampus | Wistar rat | Down |
Study M944 | Type1 | MDD group vs. control group | Anterior midcingulate cortex | Human | Up |